The Aplio i-series is a highly-advanced and scalable ultrasound solution made up of the Aplio i700 and Aplio i800, which are both cleared by the U.S. Food and Drug Administration and are ideal for shared service departments with a high patient throughput, according to the company.
Both systems include iPerformance technologies that deliver extreme processing power and allow healthcare providers to see more. A new beam-forming technology, iBeam, optimizes efficiency of the beam, increasing penetration, spatial resolution and contrast resolution, while at the same time reducing artifacts and clutter.
The i800 offers advanced clinical applications, including an ultra-high frequency transducer (24 MHz) that makes it easier for clinicians to image superficial structures and expand the use of diagnostic ultrasound.
The Aplio i-series provides intuitive ergonomics to boost productivity during daily routine and complex exams with iSense. The systems offer an image-guided user interface, which visually guides the clinician through the exam to simplify system operation and help improve efficiency. To make ultrasound exams faster, the systems feature touch control screens and real-time quick scan, which makes automatic image adjustments without pushing a button.
“The Aplio i-series raises the bar in ultrasound. The systems combine leading edge image quality with advanced clinical applications, giving our customers a clinical and cost-effective solution for today’s healthcare challenges,” said Satrajit Misra, vice president of marketing and strategic development for Toshiba America Medical Systems. “The systems also feature entirely redesigned controls and ergonomic features that make work flow, help reduce user strain and improve patient throughput.”
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including computed tomography, magnetic resonance, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States.